Table 1. Receptors as co-ordinators of complex formation, and function in genetic and epigenetic changes in gene activation.
Component | Signalling systems
|
|||
---|---|---|---|---|
IFNγ | EGF | FGF | SR | |
Ligand | IFNγ: (i) activates receptor; (ii) provides NLS [31,32] | EGF, TGFα: (i) activate receptor | FGF: (i) activates receptor; (ii) provides NLS | SH: (i) activates receptor |
Receptor | IFNGR1: (i) transcription factor/co-transcription factor [40] | EGFR: (i) transcription factor/co-transcription factor; (ii) provides NLS; (iii) RTK and other kinase activity for epigenetic modification | FGFR1, FGFR2: (i) transcription factor/co-transcription factor; (ii) RTK activity for epigenetic modification | SR: (i) transcription factor/co-transcription factor; (ii) platform for co-activators |
JAKs | IFNGR2: (i) moves JAK2 to IFNGR1 [39] (i) STAT activation; (ii) epigenetic modification [41] |
(i) STAT activation; (ii) epigenetic modification | (i) STAT activation; (ii) epigenetic modification | |
STATs | STAT1α: (i) transcription factor in activated state [41]; (ii) heterochromatin stabilizer in non-phosphorylated state [41] | STATs 1, 3, 5: (i) transcription factors | STAT5: (i) transcription factors | STAT5: (i) transcription factor for progesterone receptor [70] |
Other associated nuclear kinases and co-factors | MAPK ERK1/2 NF-κB [12] |
MAPK Src [69] |
MAPK Rsk1 [70] |
MAPK SRC 1, 2, 3 [71] Msk1 and ERK [71] |